Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tvardi Therapeutics (TVRD) Cash from Financing Activities: 2013-2017

Historic Cash from Financing Activities for Tvardi Therapeutics (TVRD) over the last 4 years, with Dec 2017 value amounting to $183,000.

  • Tvardi Therapeutics' Cash from Financing Activities rose 120.48% to $183,000 in Q4 2017 from the same period last year, while for Dec 2017 it was $87.9 million, marking a year-over-year increase of 16.18%. This contributed to the annual value of -$3.6 million for FY2024, which is 109.45% down from last year.
  • According to the latest figures from Q4 2017, Tvardi Therapeutics' Cash from Financing Activities is $183,000, which was up 21.19% from $151,000 recorded in Q3 2017.
  • Tvardi Therapeutics' 5-year Cash from Financing Activities high stood at $87.4 million for Q2 2017, and its period low was -$311,000 during Q4 2013.
  • Its 3-year average for Cash from Financing Activities is $16.4 million, with a median of $116,000 in 2016.
  • Examining YoY changes over the last 5 years, Tvardi Therapeutics' Cash from Financing Activities showed a top increase of 84,056.67% in 2015 and a maximum decrease of 267.89% in 2015.
  • Tvardi Therapeutics' Cash from Financing Activities (Quarterly) stood at -$311,000 in 2013, then spiked by 135.05% to $109,000 in 2014, then tumbled by 267.89% to -$183,000 in 2015, then soared by 145.36% to $83,000 in 2016, then skyrocketed by 120.48% to $183,000 in 2017.
  • Its Cash from Financing Activities was $183,000 in Q4 2017, compared to $151,000 in Q3 2017 and $87.4 million in Q2 2017.